BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 27556694)

  • 1. Lactoferrin selectively triggers apoptosis in highly metastatic breast cancer cells through inhibition of plasmalemmal V-H+-ATPase.
    Pereira CS; Guedes JP; Gonçalves M; Loureiro L; Castro L; Gerós H; Rodrigues LR; Côrte-Real M
    Oncotarget; 2016 Sep; 7(38):62144-62158. PubMed ID: 27556694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vacuolar H+-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity.
    Sennoune SR; Bakunts K; Martínez GM; Chua-Tuan JL; Kebir Y; Attaya MN; Martínez-Zaguilán R
    Am J Physiol Cell Physiol; 2004 Jun; 286(6):C1443-52. PubMed ID: 14761893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of plasma membrane V-ATPases is critical for the invasion of MDA-MB231 breast cancer cells.
    Cotter K; Capecci J; Sennoune S; Huss M; Maier M; Martinez-Zaguilan R; Forgac M
    J Biol Chem; 2015 Feb; 290(6):3680-92. PubMed ID: 25505184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine Milk Lactoferrin Selectively Kills Highly Metastatic Prostate Cancer PC-3 and Osteosarcoma MG-63 Cells
    Guedes JP; Pereira CS; Rodrigues LR; Côrte-Real M
    Front Oncol; 2018; 8():200. PubMed ID: 29915723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactoferrin perturbs intracellular trafficking, disrupts cholesterol-rich lipid rafts and inhibits glycolysis of highly metastatic cancer cells harbouring plasmalemmal V-ATPase.
    Santos-Pereira C; Guedes JP; Ferreira D; Rodrigues LR; Côrte-Real M
    Int J Biol Macromol; 2022 Nov; 220():1589-1604. PubMed ID: 36116593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vacuolar-ATPase Inhibition Blocks Iron Metabolism to Mediate Therapeutic Effects in Breast Cancer.
    Schneider LS; von Schwarzenberg K; Lehr T; Ulrich M; Kubisch-Dohmen R; Liebl J; Trauner D; Menche D; Vollmar AM
    Cancer Res; 2015 Jul; 75(14):2863-74. PubMed ID: 26018087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine lactoferrin induces cell cycle arrest and inhibits mTOR signaling in breast cancer cells.
    Zhang Y; Nicolau A; Lima CF; Rodrigues LR
    Nutr Cancer; 2014; 66(8):1371-85. PubMed ID: 25356800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The function of vacuolar ATPase (V-ATPase) a subunit isoforms in invasiveness of MCF10a and MCF10CA1a human breast cancer cells.
    Capecci J; Forgac M
    J Biol Chem; 2013 Nov; 288(45):32731-32741. PubMed ID: 24072707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron-free and iron-saturated bovine lactoferrin inhibit survivin expression and differentially modulate apoptosis in breast cancer.
    Gibbons JA; Kanwar JR; Kanwar RK
    BMC Cancer; 2015 May; 15():425. PubMed ID: 25998617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of vacuolar ATPase attenuates the TRAIL-induced activation of caspase-8 and modulates the trafficking of TRAIL receptosomes.
    Horova V; Hradilova N; Jelinkova I; Koc M; Svadlenka J; Brazina J; Klima M; Slavik J; Hyrslova Vaculova A; Andera L
    FEBS J; 2013 Jul; 280(14):3436-50. PubMed ID: 23678861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vacuolar-type ATPase inhibitor archazolid increases tumor cell adhesion to endothelial cells by accumulating extracellular collagen.
    Luong B; Schwenk R; Bräutigam J; Müller R; Menche D; Bischoff I; Fürst R
    PLoS One; 2018; 13(9):e0203053. PubMed ID: 30204757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH and drug resistance. I. Functional expression of plasmalemmal V-type H+-ATPase in drug-resistant human breast carcinoma cell lines.
    Martínez-Zaguilán R; Raghunand N; Lynch RM; Bellamy W; Martinez GM; Rojas B; Smith D; Dalton WS; Gillies RJ
    Biochem Pharmacol; 1999 May; 57(9):1037-46. PubMed ID: 10796074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LASS2 enhances chemosensitivity of breast cancer by counteracting acidic tumor microenvironment through inhibiting activity of V-ATPase proton pump.
    Fan S; Niu Y; Tan N; Wu Z; Wang Y; You H; Ke R; Song J; Shen Q; Wang W; Yao G; Shu H; Lin H; Yao M; Zhang Z; Gu J; Qin W
    Oncogene; 2013 Mar; 32(13):1682-90. PubMed ID: 22580606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide production by the vacuolar-type (H+)-ATPase inhibitors bafilomycin A1 and concanamycin A and its possible role in apoptosis in RAW 264.7 cells.
    Hong J; Nakano Y; Yokomakura A; Ishihara K; Kim S; Kang YS; Ohuchi K
    J Pharmacol Exp Ther; 2006 Nov; 319(2):672-81. PubMed ID: 16895977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Novel Bisbenzimidazole Derivatives as Anticancer Vacuolar (H⁺)-ATPase Inhibitors.
    Patil R; Kulshrestha A; Tikoo A; Fleetwood S; Katara G; Kolli B; Seibel W; Gilman-Sachs A; Patil SA; Beaman KD
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28926955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. V-ATPase inhibition increases cancer cell stiffness and blocks membrane related Ras signaling - a new option for HCC therapy.
    Bartel K; Winzi M; Ulrich M; Koeberle A; Menche D; Werz O; Müller R; Guck J; Vollmar AM; von Schwarzenberg K
    Oncotarget; 2017 Feb; 8(6):9476-9487. PubMed ID: 28036299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable Eri silk nanoparticles as a delivery vehicle for bovine lactoferrin against MDA-MB-231 and MCF-7 breast cancer cells.
    Roy K; Patel YS; Kanwar RK; Rajkhowa R; Wang X; Kanwar JR
    Int J Nanomedicine; 2016; 11():25-44. PubMed ID: 26730188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of silkworm vacuolar-type ATPase activity by its inhibitor Bafilomycin A1 induces caspase-dependent apoptosis in an embryonic cell line of silkworm.
    Tan XY; Wang X; Liu QS; Xie XQ; Li Y; Li BQ; Li ZQ; Xia QY; Zhao P
    Arch Insect Biochem Physiol; 2018 Nov; 99(3):e21507. PubMed ID: 30246413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. V-ATPase inhibition overcomes trastuzumab resistance in breast cancer.
    von Schwarzenberg K; Lajtos T; Simon L; Müller R; Vereb G; Vollmar AM
    Mol Oncol; 2014 Feb; 8(1):9-19. PubMed ID: 24055142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The milk-derived lactoferrin inhibits V-ATPase activity by targeting its V1 domain.
    Santos-Pereira C; Rocha JF; Fernandes HS; Rodrigues LR; Côrte-Real M; Sousa SF
    Int J Biol Macromol; 2021 Sep; 186():54-70. PubMed ID: 34237360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.